Author

Christopher L Wolfgang

NYU Grossman School of Medicine - Cited by 66,797 - Hepatobiliary and Pancreatic Surgery

Biography

Christopher Wolfgang is a General Surgeon in New York, New York. Dr. Wolfgang has been practicing medicine for over 23 years and is highly rated in 23 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Adenoma, Familial Pancreatic Cancer, and Gastrointestinal Fistula. He is board certified in General Surgery and licensed to treat patients in New York and Maryland. Dr. Wolfgang is currently accepting new patients. His clinical research consists of co-authoring 487 peer reviewed articles and participating in 3 clinical trials in the past 15 years.  
Title
Cited by
Year
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A Classification of the International Study Group of Pancreatic Surgery
F Schuh, AL Mihaljevic, P Probst, MT Trudeau, PC Müller, G Marchegiani, ...Annals of surgery 277 (3), e597, 2023202
53
2023
26
2023
The influence of intraoperative blood loss on fistula development following pancreatoduodenectomy
MT Trudeau, F Casciani, L Maggino, TF Seykora, HJ Asbun, CG Ball, ...Annals of surgery 276 (5), e527-e535, 2022202
17
2022
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
T Xia, K Li, N Niu, Y Shao, D Ding, DL Thomas, H Jing, K Fujiwara, H Hu, ...Journal of Hematology & Oncology (1), 1-20, 2022202
15
2022
Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy
JR Habib, B Kinny-Köster, P Bou-Samra, R Alsaad, E Sereni, AA Javed, ...Annals of surgery 277 (1), 151-158, 2023202
11
2023
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ...Cancer cell 40 (11), 1374-1391. e7, 2022202
10
2022
Cinematic rendering: novel tool for improving pancreatic cancer surgical planning
AA Javed, RWC Young, JR Habib, B Kinny-Köster, SM Cohen, ...Current Problems in Diagnostic Radiology 51 (6), 7-3, 2022202
8
2022
Assessment of caregivers’ burden when caring for patients with pancreatic and periampullary cancer
ZV Fong, J Teinor, TP Yeo, D Rinaldi, JB Greer, H Lavu, M Qadan, ...JNCI: Journal of the National Cancer Institute 114 (11), 146-1475, 2022202
8
2022
Prognostic utility of systemic immune-inflammation index after resection of extrahepatic cholangiocarcinoma: results from the US extrahepatic biliary malignancy consortium
J Toyoda, K Sahara, SK Maithel, DE Abbott, GA Poultsides, C Wolfgang, ...Annals of surgical oncology 29 (12), 605-614, 2022202
7
2022
Early recurrence after resection of locally advanced pancreatic cancer following induction therapy: an international multicenter study
LWF Seelen, A Floortje van Oosten, LJH Brada, VP Groot, LA Daamen, ...Annals of Surgery 28 (1), 118-126, 2023202
7
2023
The Felix project: deep networks to detect pancreatic neoplasms
Y Xia, Q Yu, L Chu, S Kawamoto, S Park, F Liu, J Chen, Z Zhu, B Li, ...medRxiv, 2022.09. 24.22280071, 2022202
6
2022
Demystifying BRAF mutation status in colorectal liver metastases: a multi-institutional, collaborative approach to 6 open clinical questions
GA Margonis, T Boerner, JB Bachet, S Buettner, R Moretto, N Andreatos, ...Annals of Surgery, 10.1097, 2022202
5
2022
Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An …
HS Kim, W Song, W Choo, S Lee, Y Han, C Bassi, R Salvia, ...Journal of Hepato‐Biliary‐Pancreatic Sciences 30 (1), 133-143, 2023202
5
2023
4
2022
Solid pseudopapillary neoplasms of the pancreas across races demonstrate disparities with comparably good prognosis
YJ Lin, R Burkhart, TP Lu, C Wolfgang, M Wright, L Zheng, HY Wu, ...World journal of surgery 46 (12), 072-080, 2022202
3
2022
Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer
AA Javed, D Ding, A Hasanain, F Van Oosten, J Yu, JL Cameron, ...Annals of surgery 277 (6), 859-865, 20220
3
2023
2
2022
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy
GD Ivey, S Shoucair, DJ Delitto, JR Habib, B Kinny-Köster, CR Shubert, ...World journal of surgery 46 (11), 751-759, 0
2
2022
Resected early-onset pancreatic cancer: practices and outcomes in an international dual-center study
CS Leonhardt, B Kinny-Köster, T Hank, JR Habib, S Shoucair, U Klaiber, ...Annals of surgical oncology 30 (4), 433-443, 030
2
2023